CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Yu Mi Kang, Chang Hee Jung
Endocrinol Metab. 2016;31(2):258-274.   Published online April 25, 2016
DOI: https://doi.org/10.3803/EnM.2016.31.2.258

Excel Download

Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists
Cardiovascular Diabetology. 2014;13(1):   Crossref logo
Link1 Link2 Link3

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
Endocrinology and Metabolism. 2016;31(2):258   Crossref logo
Link1 Link2 Link3

Glucagon-like peptide-1 receptor agonists and cardiovascular disease: from LEADER to EXSCEL
Cardiovascular Research. 2018;114(10):e70-e71   Crossref logo
Link1

Clinical application of glucagon-like peptide-1 receptor agonists in cardiovascular disease: lessons from recent clinical cardiovascular outcomes trials
Cardiovascular Diabetology. 2018;17(1):   Crossref logo
Link1 Link2 Link3

Cardiovascular effects of glucagon-like peptide 1 receptor agonists: from mechanistic studies in humans to clinical outcomes
Cardiovascular Research. 2019;116(5):916-930   Crossref logo
Link1 Link2 Link3

Organoprotective effects of glucagon-like peptide-1 receptor agonists with regard to findings of evidencebased cardiovascular safety studies
Medical Council. 2020;(21)189-197   Crossref logo
Link1

Glucagon-like peptide-1 receptor agonists and their effects on weight reduction
Journal of Diabetes Investigation. 2012;3(6):490-491   Crossref logo
Link1 Link2

Cardiovascular safety of albiglutide and other glucagon-like peptide-1 receptor agonists
The Lancet Diabetes & Endocrinology. 2015;3(9):667-669   Crossref logo
Link1 Link2

Glucagon-like peptide-1 receptor agonists
Handbook of Incretin-based Therapies in Type 2 Diabetes. 2016;31-43   Crossref logo
Link1

Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials
Diabetes, Obesity and Metabolism. 2013;16(1):38-47   Crossref logo
Link1 Link2